Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
Clinical trial NCT04164979 · COMPLETED
Trial details
- NCT number
- NCT04164979
- Sponsor
- University of California, Irvine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2023-11-25
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.